Tate & Lyle account plan
Healthy tastier food ingredients
At a glance
Tate & Lyle makes sweetening, mouthfeel and fortification ingredients for food and drink makers in 120 countries; FY2026 revenue was £2,006m.
Tate & Lyle is a speciality food and beverage ingredients business that turns crops such as corn, stevia and citrus peel into over 1,000 ingredients for sweetening, mouthfeel and fortification, mainly for beverage, dairy, soups, sauces and dressings, and bakery and snacks. After combining with CP Kelco in November 2024 it had 4,840 employees, 24 manufacturing sites in 11 countries and customers in 120 countries at 31 March 2026. In the year to 31 March 2026 statutory revenue was £2,006m, adjusted EBITDA £415m and statutory profit before tax £131m. It is a UK-listed PLC whose shareholders approved a recommended acquisition by Ingredion on 28 July 2026, with completion expected in the second half of calendar 2027.
Business units
Americas
about 50% of FY2026 revenue (£995m)Sells the full portfolio in North America (c.75% of the region) and Latin America; FY2026 adjusted EBITDA was £258m at a 26.0% margin, with revenue down 3% as consumer demand softened after tariffs. In H1 FY2027 revenue was £521m (+1%) with EBITDA flat at £134m. Led since December 2025 by Didier Viala, previously CP Kelco's Chief Executive.
Europe, Middle East and Africa
about 32% of FY2026 revenue (£636m)Covers Europe and Turkey, Middle East and Africa, with corn wet mills in the Netherlands and Slovakia and pectin plants in Denmark and Germany. FY2026 revenue fell 5% on lower pricing, with European bulk sweeteners and co-products a large part of the decline. In H1 FY2027 revenue was £308m (-4%) and EBITDA fell 28% to £36m on pricing and energy inflation.
Asia Pacific
about 19% of FY2026 revenue (£375m)Revenue has more than doubled in six years; FY2026 adjusted EBITDA rose 9% to £56m. In H1 FY2027 revenue grew 7% to £210m on volume/mix +9%, led by North Asia, ASEAN, Australia and New Zealand and India, while China was modestly down; the company is investing in India, South East Asia and China food service.
Strategic priorities
- Volume-led top-line growth
- The stated number one priority is to deliver volume-led top-line growth, through customer segmentation into partner, enterprise, accelerator and core accounts, realigned customer-facing teams and solution selling; solutions reached 58% of new business wins by value in H1 FY2027.
- CP Kelco combination benefits
- The US$50m cost synergy run-rate was reached; revenue synergies of around US$70 million (10% of CP Kelco's revenue) are targeted by end FY2029, through cross-selling and moving CP Kelco customers from distributors to direct service.
- Productivity programme
- Savings of US$171m over three and a half years, with the target raised to US$200m by 31 March 2028 under the "Fuelling Growth" programme.
- Balance sheet and cash conversion
- Cash conversion above 75% each year, a progressive dividend and a long-term leverage target of 1x to 2.5x; leverage was 2.3x on a covenant basis at H1 FY2027.
- Expansion in higher-growth markets and fibre
- Growth in Asia, Middle East, Africa and Latin America, and in fibres such as PROMITOR Soluble fibre, with a target to provide 35 billion servings of 15 g of fibre by 2030.
Latest results
For the six months to 30 September 2026, revenue was £1,039m, up 1% in constant currency, with volume/mix +3% partly offset by a 2% price decline; excluding US tariff reimbursements and European bulk sweeteners, revenue grew 2%. Adjusted EBITDA fell 8% to £197m (margin 19.0%) on pricing, investment in capabilities and IT, and cost inflation, particularly in EMEA, and statutory profit before tax fell 37% to £46m. Free cash flow was £100m at 75% cash conversion and net debt £959m. The FY2027 outlook is maintained: modest revenue growth weighted to the second half and broadly flat EBITDA before the c.US$20 million bio-gums rescheduling impact, with cost inflation to be passed through in the 2027 framework agreements.
Investments and deals
- Ingredion acquisition
- Ingredion's recommended offer of up to 615 pence per share was approved by shareholders on 28 July 2026 with 98.64% of votes in favour; approvals are received in six jurisdictions, six remain, and completion is expected in the second half of calendar 2027.
- CP Kelco integration
- The combination completed on 15 November 2024 and the group has operated as one company since 1 April 2025; integration costs were £35m in FY2026 and £11m in H1 FY2027.
- Bio-gums capacity consolidation
- The expected c.US$20 million benefit moved from FY2027 to FY2028; the consolidation is progressing as planned.
- Commercial technology
- Around US$10 million in new technology and digital tools, including a generative AI tool for sales and technical teams, and a single common CRM platform implemented in August 2026.
- Capital expenditure
- FY2027 capex guidance is £110m to £130m; H1 FY2027 capex was £48m. A group-wide warehousing optimisation project is planned.
Challenges and risks
- Cost inflation in Europe
- The Middle East conflict has been more protracted than anticipated, with effects more pronounced in Europe; EMEA EBITDA fell 28% in H1 FY2027 and the company calls it a tougher cost environment than anticipated.
- Soft consumer demand and pricing
- Consumer demand softened after tariffs, affordability is an issue in Europe and the US, and strategic pricing actions cost 2% of revenue in H1 FY2027.
- Declining bulk sweeteners
- European bulk sweeteners and co-products accounted for around 40% of the EMEA FY2026 revenue decline on lower sugar pricing.
- Competition from China
- Excess China capacity has heightened competition elsewhere in Asia, in sweeteners and some gums.
- Takeover uncertainty
- Because the Ingredion deal may complete in the going concern period, the directors and auditor flag a material uncertainty related to going concern.
What leadership says
“The Group performed well in the first half with a return to top-line growth and profit in line with our expectations.”
“As we move into the 2027 financial year, we are determined to put that right.”
“crystal clear: deliver top-line growth and improve our financial performance”
“the litmus test will be how we perform in the coming financial year and beyond”
Where a supplier can help
- Sales enablement and CRM
- The new customer segmentation, single CRM platform, generative AI tool and Commercial Academy for solution selling create demand for sales analytics, content and training tools.
- Energy and procurement savings
- Cost inflation in European energy and the US$200m productivity target open doors for energy management, procurement and process-efficiency suppliers.
- Plant operations and fermentation scale-up
- The bio-gums consolidation, Six Sigma productivity projects at plants like Lafayette and a plant equipment failure in H1 FY2027 point to needs in process engineering, maintenance and reliability.
- Warehousing and supply chain
- The planned group-wide warehousing optimisation and inventory built to manage tariffs suggest openings for logistics and supply-chain planning partners.
- Integration and post-merger services
- The pending Ingredion acquisition and the CP Kelco integration involve systems, data and organisational work where advisers and integrators can help.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Tate & Lyle?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Tate & Lyle PLC Annual Report 2026 (year ended 31 March 2026)
- Tate & Lyle is a speciality food and beverage solutions business, "a global leader in sweetening, mouthfeel and fortification", combined with CP Kelco (acquired 15 November 2024) and operating as one company since 1 April 2025; 4,840 employees, 75 plants, offices and labs, customers in 120 countries, 21 Customer Innovation and Collaboration Centres.
- FY to 31 March 2026 (continuing operations): statutory revenue £2,006m (+16% reported, 2025: £1,736m), profit before tax £131m, diluted EPS 21.7p; adjusted EBITDA £415m (margin 20.7%), adjusted diluted EPS 40.4p (2025: 50.3p), free cash flow £164m, net debt £939m, leverage 2.3x.
- On a pro forma basis Group revenue and adjusted EBITDA were both 3% lower in constant currency: the expected demand recovery "did not materialise", notably in North America, with tariffs and lower European bulk sweetener pricing weighing.
- Three regional segments: Americas £995m revenue / £258m EBITDA, Europe, Middle East and Africa £636m / £101m, Asia Pacific £375m / £56m (EBITDA +9%).
- Four priorities to restore top-line growth: targeted investment to accelerate customer wins (customer segmentation, solutions chassis, c.US$10m in digital tools incl. a generative AI tool), deliver CP Kelco benefits (US$50m run-rate cost synergies reached; revenue synergies of around US$70m targeted by FY2029), productivity (US$53m in the year, five-year target raised to US$200m by FY2028), balance sheet and returns.
- Addressable market US$20bn (mouthfeel around US$11bn, sweetening around US$6bn, fortification around US$3bn); New Products revenue £336m, +9% like-for-like; £86m invested in innovation and solution selling; solutions 35% of new business wins.
- Ingredion made a conditional cash proposal on 14 May 2026 of up to 615 pence per share (595p cash plus permitted dividends); final dividend 13.2p, total 19.8p, flat.
- Leadership changes: Melissa Law Chief Commercial and Transformation Officer, Kim Faulkner Chief Supply Chain Officer (ex Colgate-Palmolive), Didier Viala (ex CP Kelco CEO) President, Americas.
- Outlook FY2027: modest revenue growth weighted to H2, broadly flat EBITDA before the c.US$20 million impact of rescheduling the bio-gums capacity consolidation.
- Results for the six months to 30 September 2026
- H1 to 30 September 2026: revenue £1,039m, +1% in constant currency (volume/mix +3%, price -2%), or +2% excluding European bulk sweeteners/co-products and US tariff reimbursements; adjusted EBITDA £197m, -8%, margin 19.0% (-190bps), in line with management expectations.
- Statutory operating profit £74m, profit before tax £46m (-37%), diluted EPS 6.3p; adjusted EPS 17.5p; free cash flow £100m, cash conversion 75%; net debt £959m, 2.4x reported leverage.
- Segments: Americas £521m (+1%, EBITDA £134m flat); Europe, Middle East and Africa £308m (-4%, EBITDA £36m -28% on pricing and energy inflation); Asia Pacific £210m (+7%, volume/mix +9%, EBITDA £27m -13%).
- Ingredion's recommended acquisition was approved by shareholders on 28 July 2026 with 98.64% in favour; completion expected in H2 of calendar 2027; £21m of Ingredion deal-related costs in the half.
- Commercial execution: a single common CRM platform introduced, double-digit revenue growth in Accelerator accounts, double-digit growth of PROMITOR® Soluble corn fibre, 22 solution chassis launched in total.
- Solutions represented 58% of new business wins by value (+15ppts); new business pipeline US$433 million, +17% like-for-like; New Product revenue £160m (+4% like-for-like).
- Productivity savings US$27m in H1, US$171m over three and a half years; capex £48m, FY2027 capex guided at £110m-£130m.
- FY2027 outlook maintained; the Middle East conflict has made cost inflation "more pronounced than originally anticipated" and the company intends to pass it through in 2027 customer framework agreements.
- Interim dividend 6.8p (2025: 6.6p).
- H1 FY2027 results presentation transcript
- CEO Nick Hampton and CFO Sarah Kuijlaars presented H1 FY2027 (six months to 30 September 2026) on 5 November 2026, with three messages: return to volume-led revenue growth, strategic actions delivering results, full-year outlook maintained.
- Ingredion's offer (up to GBP 6.15 per share including dividends) was approved by over 98% of shareholders in July; completion still expected in H2 of calendar 2027.
- Revenue +1% (+2% underlying, volume mix 4%); higher-value specialty products are approximately 2/3 of revenue; EBITDA GBP 197 million, -8%, hit by pricing, European energy inflation and investment in China food service and India.
- Customers are segmented into partner accounts, enterprise accounts, accelerators and core accounts; a single common CRM platform went live in August and a generative AI tool cut a 2-3 day analysis to under one hour.
- Fibre is a key growth area: polydextrose revenue +29% in the Americas, PROMITOR Soluble fibres +52% (Americas) and +15% (Asia Pacific); pladis/McVitie's Penguin Bites cited as a fibre-fortification win.
- Solutions 58% of new business wins (+15 points), 22 chassis available, new business pipeline +17% like-for-like.
- Productivity US$27 million in H1 from over 300 projects, US$171 million over three and a half years; leverage target 1x-2.5x, currently 2.3x covenant.
- New SBTi-validated 1.5°C emissions targets and a 2030 target of 35 billion servings of 15 g of fibre.
- H1 FY2027 results Q&A conference call transcript
- Live analyst Q&A on H1 FY2027 results, 5 November 2026, with CEO Nick Hampton and CFO Sarah Kuijlaars (analysts from Barclays, Deutsche Numis, BNP Paribas, Goodbody).
- Ingredion deal: written or verbal approval in six jurisdictions (Brazil, China, UK, South Korea, Tanzania, Zanzibar); six remain (Canada, Colombia, Mexico, US merger control, and EU merger control and Foreign Subsidies Regulation); completion still expected in H2 calendar 2027.
- Cost inflation from the Middle East conflict is more pronounced, mainly in Europe; Hampton will not quantify the pass-through and expects the 2027 framework agreement round to happen later because of volatility.
- Volume mix +3% (4% like-for-like) reflects CP Kelco benefits "only 18 months" in, last year's framework agreements and a growing pipeline focused on higher-value ingredients.
- Regional picture: very strong broad-based Asia Pacific, encouraging India, growth in North America despite consumers, solid LATAM; Europe the challenge, where the company "did have to put some price into the market".
- Fibre: "a smaller part of our portfolio today, but it is growing very rapidly", expected to continue for 12-18 months.
- Demand: Northern Hemisphere consumers "remains more challenged"; growth is "more innovation and customer-driven than consumer-driven", with clean label, fibre fortification and health and wellness in the pipeline.
- Bio-gums consolidation "on track"; H2 EBITDA has "not a significant step up" versus H1 in absolute terms.
- FY2026 results presentation and Q&A transcript (Bloomberg)
- FY2026 results call (21 May 2026) with CEO Nick Hampton and CFO Sarah Kuijlaars, a week after Ingredion's conditional proposal, which management could not discuss.
- Four messages: CP Kelco integration complete; results in line with October's revised guidance; progress on the four November priorities; leverage the combination to accelerate growth. Financial performance described as "disappointing".
- Pro forma revenue and EBITDA (GBP415 million) both -3%; about 20% of the revenue decline came from European bulk sweeteners and 30% from Latin American (notably Mexico) sweetening softness; around two-thirds of the portfolio grew.
- Number one priority for FY2027: volume-led top-line growth; customers segmented into partner, enterprise, accelerator and core accounts; 18 solution chassis in market, 9 in development; a generative AI tool rolled out from February.
- CP Kelco: US$50 million cost synergy run rate reached a year early; around 10% of the ~US$70 million revenue synergy target delivered; cross-selling pipeline over US$100 million.
- Productivity US$53 million in FY2026 from over 500 projects; target raised to US$200 million; bio-gums benefit of some US$20 million pushed to FY2028 because scaling up fermentation is taking longer.
- Middle East: about 1% of revenue goes to affected countries; energy about 5% of costs and hedged through H1; freight cost pass-through prioritised.
- On Ingredion overlap Hampton would only say "We both make starches"; the Primient supply agreement "survives change of control".
Questions about Tate & Lyle
What does Tate & Lyle do?
Tate & Lyle makes speciality food and beverage ingredients for sweetening, mouthfeel and fortification, such as stevia, sucralose, pectins, gums, starches and fibres. Food and drink makers use them to cut sugar, calories and fat or add fibre.
What is Tate & Lyle's revenue?
Statutory revenue was £2,006m in the year to 31 March 2026, and £1,039m in the six months to 30 September 2026.
How many employees does Tate & Lyle have?
It had 4,840 employees at 31 March 2026, with sites in 38 countries.
Who leads Tate & Lyle?
Nick Hampton is Chief Executive, Sarah Kuijlaars Chief Financial Officer and David Hearn Chair.
Is Tate & Lyle being acquired?
Yes. Shareholders approved Ingredion's recommended offer on 28 July 2026, and completion is expected in the second half of calendar 2027, subject to regulatory approvals.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)